Series B Round
Series B is a growth-stage VC round that funds scaling a proven business. Typically requires $8–15M ARR, 80%+ YoY growth, and NRR above 110%.
What Is a Series B Round?
A Series B round is an institutional venture capital financing round raised after a startup has already demonstrated repeatable, scalable growth. Where a Series A proves that a go-to-market motion exists, a Series B funds the systematic scaling of that motion - expanding the sales team, entering new markets, and building the organizational infrastructure needed to support rapid growth.
Series B rounds in the US typically range from $20M to $50M. In Europe, the range is somewhat compressed at $10M to $25M. The investors are larger VC funds and growth equity firms - often names like Insight Partners, General Atlantic, Tiger Global, or the growth arms of top-tier firms - some of which cross over from public market investing.
Series B vs. Series A: Key Differences
| Dimension | Series A | Series B |
|---|---|---|
| Revenue | $1M–$3M ARR | $8M–$15M ARR |
| Growth rate | 15–20% MoM | 80–100%+ YoY |
| Round size (US) | $8M–$20M | $20M–$50M |
| Investor type | Early-stage VCs | Growth equity, larger VCs |
| Dilution | 20–25% | 15–20% |
| Valuation | $20M–$80M post | $100M–$400M post |
| Focus | Prove GTM | Scale GTM |
The core distinction: Series A asks “can this work?” and Series B asks “can this work at scale?” The diligence process reflects that shift.
The Metrics Bar for Series B in 2024–25
Investors at this stage are not just looking at top-line growth. They are scrutinizing whether the unit economics hold as the business scales:
| Metric | Series B Benchmark |
|---|---|
| ARR | $8M–$15M minimum |
| YoY ARR growth | 80–100%+ |
| Net Revenue Retention (NRR) | >110% |
| Gross margin (SaaS) | >70% |
| LTV : CAC | >4:1 |
| CAC payback | <24 months |
| Magic Number | >0.75 |
The NRR threshold is particularly important at Series B. An NRR above 110% means existing customers expand faster than they churn, which compresses the effective CAC over time and de-risks the growth thesis.
What Series B Capital Is Used For
Unlike a seed round (which funds product discovery) or a Series A (which funds early GTM), Series B capital is almost entirely allocated to scaling:
- Sales team expansion: Moving from 5–10 AEs to 30–50+, including mid-market and enterprise sales motion buildout
- International expansion: Often the first move into Europe or APAC markets
- Product platform investment: Shifting from a point solution to a broader platform that increases switching costs
- Marketing and demand generation: Paid acquisition at scale, brand campaigns, analyst relations
- Management team completeness: Hiring a CFO, CPO, VP of Engineering, or CRO for the first time
How the Fundraising Process Differs from Series A
At Series A, a strong deck and a credible founding team with early traction can often get a deal done. At Series B, the process is significantly more rigorous:
- Data room depth: Investors expect a complete set of cohort analyses, a detailed financial model with 3–5 year projections, an org chart, and a competitive landscape document
- Financial modeling expectations: CFO-level scrutiny of assumptions - headcount plans, sales capacity models, and NRR projections all get pressure-tested
- Reference checks: Not just founder references but customer references, early employee references, and checks on the management team
- Cohort analysis: Investors want to see retention curves across multiple cohorts to confirm that retention is stable (or improving) as the customer base scales - not just solid in the first small cohort
The typical timeline is 3–5 months from first meetings to close, slightly longer than Series A.
Valuation Multiples at Series B
Valuation at Series B is almost always quoted as a multiple of ARR. In 2021, multiples of 30–60× ARR were common for top SaaS companies. In the 2023–24 market, a realistic range for high-quality companies is 8–20× forward ARR, with the top decile reaching 20–30× for companies showing exceptional growth and retention.
A company with $12M ARR, 100% YoY growth, and 115% NRR might realistically achieve a $150M–$200M post-money valuation at Series B in today’s market.
The Investor Focus: What Gets Deals Done (or Killed)
What Series B investors lose sleep over:
- Cohort degradation: If retention in newer cohorts is worse than earlier cohorts, it suggests the company has already served the easiest customers and is moving into harder territory
- Sales efficiency decline: A rising CAC or declining Magic Number as headcount grows is a red flag that the GTM motion does not scale linearly
- Management team gaps: Missing a CFO or CRO at this stage signals execution risk at exactly the moment when operational rigor matters most
- Concentration risk: If the top 3 customers represent more than 30% of ARR, the business is not yet scaled enough to de-risk the revenue base
Key Takeaway
A Series B is not just a bigger Series A - it is a fundamentally different type of financing event that requires demonstrating that growth is durable, unit economics hold at scale, and the team is capable of running a much larger, more complex organization. Founders who raise Series B successfully treat it as a proof of operational maturity, not just revenue growth.
Comments
Loading comments...